X0306 4 2020-08-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001524803 Stolz Brian M. C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 Chief Operating Officer Common Stock 2020-08-16 4 M 0 1595 A 25167 D Common Stock 2020-08-16 4 F 0 552 28.53 D 24615 D Restricted Stock Units 2020-08-16 4 M 0 1595 0.00 D Common Stock 1595 23937 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Includes 733 shares acquired by the Reporting Person on August 14, 2020 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,595 shares of Common Stock underlying the Reporting Person's Restricted Stock Units. The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. 6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. /s/ Tara Condon, Attorney-in-Fact 2020-08-18